Report error Found 94 Enz. Inhib. hit(s) with all data for entry = 13555
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.254nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.254nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.254nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.279nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.471nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.574nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.642nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.667nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.720nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.980nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.02nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.41nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.73nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.79nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.80nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.84nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.87nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 2nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 2.07nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 2.47nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 2.5nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 2.70nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 2.72nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 2.89nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 3.08nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 3.09nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 3.38nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 3.44nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 3.48nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 3.51nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 3.72nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 3.81nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 4nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 4.17nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 4.33nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 4.51nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 4.80nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 4.82nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 4.87nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 4.93nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 4.94nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 4.98nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 5.06nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 5.14nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 5.30nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [G2019S](Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 5.40nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 5.42nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 5.47nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 5.51nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Whan In Pharmaceutical Co.
US Patent
Whan In Pharmaceutical Co.
US Patent
Affinity DataIC50: 5.91nMAssay Description:The activity of the isolated recombinant JAK1 and JAK2 kinase domain was measured by monitoring phosphorylation of a peptide derived from JAK3 (Val-A...More data for this Ligand-Target Pair
Ligand Info
